WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Stock Ownership - Who owns Corcept Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Corcept Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
David L. MahoneyDirector2024-04-102,194$23.80
$52.22kSell
David L. MahoneyDirector2024-04-1030,000$1.74
$52.20kBuy
Joseph Douglas LyonChief Accounting Technology Officer2024-04-045,443$26.00
$141.52kSell
Joseph Douglas LyonChief Accounting Technology Officer2024-04-045,443$11.35
$61.78kBuy
Joseph Douglas LyonChief Accounting Technology Officer2024-04-01500$11.35
$5.68kBuy
Joseph Douglas LyonChief Accounting Technology Officer2024-04-01500$26.01
$13.00kSell
Daniel N. Swisher Jr.Director2024-04-012,200$5.86
$12.89kBuy
Daniel N. Swisher Jr.Director2024-04-012,200$25.30
$55.66kSell
Sean MaduckOfficer2024-03-2725,953$25.01
$649.03kSell
Sean MaduckOfficer2024-03-2725,953$3.88
$100.70kBuy

1 of 13

CORT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CORT insiders and whales buy or sell their stock.

CORT Shareholders

What type of owners hold Corcept Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Patrick G. Enright43.28%44,802,403$1.03BInsider
Blackrock Inc15.85%16,407,696$377.38MInstitution
Bakker Juliet Tammenoms10.71%11,089,541$255.06MInsider
Longitude Venture Partners LP10.58%10,956,002$251.99MInsider
Alta Biopharma Partners Ii LP9.64%9,982,720$229.60MInsider
Vanguard Group Inc9.21%9,537,532$219.36MInstitution
G. Leonard Baker Jr.8.89%9,200,067$211.60MInsider
Ingalls Snyder LLC8.07%8,351,827$192.09MInstitution
Tench Coxe6.66%6,890,503$158.48MInsider
Joseph C. Cook Jr.6.54%6,765,805$155.61MInsider

1 of 3

CORT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CORT30.65%69.35%Net BuyingNet Buying
MRUS87.00%13.00%Net Selling
CGON0.00%16.44%Net BuyingNet Buying
ARVN74.74%25.26%Net SellingNet Selling
DNLI56.52%43.48%Net SellingNet Selling
View Top Biotech Stocks

Corcept Therapeutics Stock Ownership FAQ

Who owns Corcept Therapeutics?

Corcept Therapeutics (NASDAQ: CORT) is owned by 81.88% institutional shareholders, 185.27% Corcept Therapeutics insiders, and 0.00% retail investors. Patrick G. Enright is the largest individual Corcept Therapeutics shareholder, owning 44.80M shares representing 43.28% of the company. Patrick G. Enright's Corcept Therapeutics shares are currently valued at $1.02B.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.